GLYCOMIMETICS INC Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Glycomimetics Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2024.
  • Glycomimetics Inc Operating Lease, Payments for the quarter ending September 30, 2024 was $196K, a 31.1% decline year-over-year.
  • Glycomimetics Inc Operating Lease, Payments for the twelve months ending September 30, 2024 was $761K, a 32.3% decline year-over-year.
  • Glycomimetics Inc annual Operating Lease, Payments for 2023 was $1.02M, a 7.85% decline from 2022.
  • Glycomimetics Inc annual Operating Lease, Payments for 2022 was $1.1M, a 2.5% increase from 2021.
  • Glycomimetics Inc annual Operating Lease, Payments for 2021 was $1.08M, a 2.5% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $761K $196K -$88.8K -31.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $850K $196K -$84.2K -30% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $934K $196K -$83.4K -29.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.02M $172K -$107K -38.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $1.13M $285K +$6.95K +2.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $1.12M $281K +$6.84K +2.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.11M $280K +$6.82K +2.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $1.1M $280K +$6.82K +2.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $1.1M $278K +$6.79K +2.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $1.09M $274K +$6.68K +2.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $1.08M $273K +$6.66K +2.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $1.08M $273K +$6.66K +2.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-27
Q3 2021 $1.07M $271K +$6.62K +2.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.06M $267K +$6.51K +2.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $1.06M $266K +$6.49K +2.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $1.05M $266K Oct 1, 2020 Dec 31, 2020 10-K 2023-03-29
Q3 2020 $265K +$5.75K +2.22% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $260K +$5K +1.96% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $260K +$6.34K +2.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q3 2019 $259K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $255K Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $253K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.